Circadian Rhythm Impact on TNBC Response to Neoadjuvant Immunotherapy

NCT06880029 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER_GOV

Sponsor class

Conditions

Triple Negative Breast Cancer (TNBC)

Interventions

OTHER: Morning pembrolizumab infusions

Sponsor

Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.